Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
AstraZeneca
Teva
McKesson
Queensland Health
Fuji
Express Scripts
Cipla
Healthtrust

Generated: August 19, 2017

DrugPatentWatch Database Preview

LAMIVUDINE Drug Profile

« Back to Dashboard

What is the patent landscape for Lamivudine, and what generic Lamivudine alternatives are available?

Lamivudine is a drug marketed by Mylan Pharms Inc, Apotex, Lupin Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Apotex Inc, Hetero Labs Ltd V, Silarx Pharms Inc, Appco Pharma Llc, Centaur Pharms Pvt, Pharmacare, Hetero Labs Ltd Iii, Strides Pharma, and Teva Pharms. and is included in twenty-three NDAs.

The generic ingredient in LAMIVUDINE is lamivudine; zidovudine. There are twenty-seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. There are fifty tentative approvals for this compound. Additional details are available on the lamivudine; zidovudine profile page.

Summary for Tradename: LAMIVUDINE

Patents:0
Applicants:14
NDAs:23
Suppliers / Packagers: see list20
Bulk Api Vendors: see list86
Clinical Trials: see list515
Patent Applications: see list2,075
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LAMIVUDINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
LAMIVUDINE AND ZIDOVUDINE
lamivudine; zidovudine
TABLET;ORAL090246-001May 15, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
LAMIVUDINE AND ZIDOVUDINE
lamivudine; zidovudine
TABLET;ORAL077558-001May 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
LAMIVUDINE
lamivudine
TABLET;ORAL204002-001Dec 31, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Appco Pharma Llc
LAMIVUDINE
lamivudine
TABLET;ORAL206974-002Nov 21, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
LAMIVUDINE AND ZIDOVUDINE
lamivudine; zidovudine
TABLET;ORAL202418-001May 15, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Army
Dow
Express Scripts
Mallinckrodt
Fish and Richardson
Teva
UBS
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot